Proteomics reveal biomarkers for diagnosis, disease activity and long-term disability outcomes in multiple sclerosis.
Åkesson J, Hojjati S, Hellberg S, Raffetseder J, Khademi M, Rynkowski R, Kockum I, Altafini C, Lubovac-Pilav Z, Mellergård J, Jenmalm MC, Piehl F, Olsson T, Ernerudh J, Gustafsson M.
Åkesson J, et al.
Nat Commun. 2023 Oct 30;14(1):6903. doi: 10.1038/s41467-023-42682-9.
Nat Commun. 2023.
PMID: 37903821
Free PMC article.